Skip to main content
. Author manuscript; available in PMC: 2015 Mar 23.
Published in final edited form as: Gynecol Oncol. 2014 Jun 10;134(2):267–273. doi: 10.1016/j.ygyno.2014.06.002

Table 3.

Other studies with centralized pathology review of women with a serous borderline ovarian tumor (SBT) including more than 100 women.

Reference (year) Country Study period (total) No. of cases Age at diagnosis (years)
FIGO stage
Years of follow-up (years)
Median/mean (Range) I II–IV Unstaged Median/mean (Range) Women-years**
Hannibal et al. Denmark 1978–2002 (25 years) 1042 50 (15–96) 886 (85%) 145 (14%) 11 (1%) 15 (0–36) 16 183
Du Bois et al. (2013) Germany 1998–2008 (11 years) 644 48 (14–91) 489 (76%) 155 (24%) 3.4* NA 2200
Park et al. (2011) Korea 1990–2010 (10 years) 130 44 (14–87) 108 (83%) 22 (17%) 4.5 (0.4–20) 753
Quddus et al. (2011) USA 1991–2005 (15 years) 188 NA NA 171 (91%) 17 (9%) 5.6 (0.6–22) 1058
Shih et al. (2011) USA 1979–2008 (30 years) 196 43* (15–94) 133 (68%) 63 (32%) 3.7* (0–23) 725
Uzan et al. (2011) France 1969–2006 (38 years) 154 36 (14–74) 0 (0%) 168 (100%) 4.4 (1–36) 643
Kane et al. (2009) France 1973–2006 (34 years) 168 36 (14–77) 41 (25%) 127 (75%) 4.8 (0.1–36) 760
Akeseon et al. (2008) Sweden 1993–2004 (12 years) 219 55* (16–90) 197 (82%) 22 (10%) 7.7* (2–13) 1687
De laco et al. (2008) Italy 1985–2006 (22 years) 102 46* (14–85) 72 (71%) 30 (29%) 5.0* (0.3–20) 514
Ren et al. (2008) China 2001–2007 (7 years) 101 40* (14–80) 66 (65%) 35 (35%) 3.3* (0.7–7) 337
Cusido et al. (2007) Spain 1990–1997 (8 years) 208 46* NA 177 (85%) 21 (10%) 10 (5%) 7.3* NA 1525
Longacre et al. (2005) USA 1958–1998 (41 years) 276 51 (12–89) 163 (59%) 113 (41%) 9.2 (0.7–48) 2500
Prat and Nictolis (2002) Spain 1980–1998 (19 years) 137 39 (14–84) 92 (67%) 45 (33%) 7.2 (1–18) 762
Zanetta et al. (2001) Italy 1982–1997 (16 years) 205 39* NA 171 (83%) 34 (17%) 5.8* (1–15) 1155
Rota et al. (1999) Italy 1982–1996 (15 years) 188 46* (16–74) 125 (66%) 18 (10%) 45 (24%) 6.6* (0.8–14) 1238
Barnhill et al. (1995) USA 1983–1992 10 years) 146 44 (19–79) 146 (100%) 0 (0%) 3.5 (0.8–14) 516
Kaern et al. (1993) Norway 1970–1982 (13 years) 174 53* (15–83) 148 (85%) 26 (15%) 12.4* (0.4–21) 2161
Trope et al. (1993) Norway 1970–1988 (19 years) 114 48* (15–81) 109 (96%) 5 (4%) 12.3* (0.3–21) 1397
Leake et al. (1992) USA 1979–1984 (6 years) 200 34 (6–98) 135 (67.5%) 65 (32.5%) 10 (4–27) 2240

Abbreviations: International Federation of Gynecology and Obstetrics (FIGO); number (No.); not available (NA). If a study population is published several times, only data from the newest paper is presented in the table.

*

Also based on women with other histologic subtypes of borderline ovarian tumors.

**

Calculated based on the number of women included in the study (N) and the number of median/mean years of follow-up (M) (N × M = women-years of follow-up).